Patents by Inventor Ramy A. Mahmoud

Ramy A. Mahmoud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285278
    Abstract: A method of delivering a substance, such as fluticasone propionate, a nasal steroid and/or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of sinus and/or nasal inflammatory diseases, for example, chronic rhinosinusitis with or without nasal polyps, to reduce sinus inflammation, reduce sinus opacification, and/or improve associated symptoms.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 14, 2023
    Inventors: Ramy MAHMOUD, John MESSINA
  • Patent number: 11730904
    Abstract: A delivery device for and method of modulating a condition relating to social cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: August 22, 2023
    Assignee: OptiNose, Inc.
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, Ole A Andreassen, Lars T. Westlye, Daniel S. Quintana, Knut T. Smerud, Colin David Sheldrake
  • Publication number: 20230166061
    Abstract: A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
    Type: Application
    Filed: December 12, 2022
    Publication date: June 1, 2023
    Inventors: Per Gisle DJUPESLAND, Ramy A. MAHMOUD, John MESSINA
  • Patent number: 11554229
    Abstract: A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: January 17, 2023
    Assignee: OptiNose Inc.
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, John Messina
  • Publication number: 20220152324
    Abstract: A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject: a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece.
    Type: Application
    Filed: July 2, 2021
    Publication date: May 19, 2022
    Inventors: Per Gisle DJUPESLAND, Joseph GORDON, Michael LECLERC, Ramy A. MAHMOUD, Shane SIWINSKI
  • Publication number: 20210322690
    Abstract: A delivery device for and method of modulating a condition relating to social cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
    Type: Application
    Filed: June 4, 2021
    Publication date: October 21, 2021
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, Ole A. Andreassen, Lars T. Westlye, Daniel S. Quintana, Knut T. Smerud, Colin David Sheldrake
  • Publication number: 20210290867
    Abstract: A nasal delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: a nosepiece (117) for fitting to a nasal cavity of a subject, a mouthpiece (119) into which the subject in use exhales; a delivery unit, which comprises an actuation part which is manually displaceable to actuate the delivery unit to deliver substance from the nosepiece; and a valve assembly (127) which is fluidly connected to the nosepiece and the mouthpiece, wherein the valve assembly comprises a body element (128) and a valve element (131) which is movably disposed to the body element between closed and open configurations by manual displacement of the actuation part of the delivery unit to provide for an air flow through the nosepiece simultaneously with delivery of substance.
    Type: Application
    Filed: May 11, 2021
    Publication date: September 23, 2021
    Inventors: Per Gisle DJUPESLAND, Michael LECLERC, Ramy A. MAHMOUD, Shane SIWINSKI, Joseph GORDON, Justin FISK
  • Patent number: 11052204
    Abstract: A delivery device for and method of modulating a condition relating to sodal cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: July 6, 2021
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, Ole A Andreassen, Lars T. Westlye, Daniel S. Quintana, Knut T. Smerud, Colin David Sheldrake
  • Patent number: 11033696
    Abstract: A nasal delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: a nosepiece (117) for fitting to a nasal cavity of a subject; a mouthpiece (119) into which the subject in use exhales; a delivery unit, which comprises an actuation part which is manually displaceable to actuate the delivery unit to deliver substance from the nosepiece; and a valve assembly (127) which is fluidly connected to the nosepiece and the mouthpiece, wherein the valve assembly comprises a body element (128) and a valve element (131) which is movably disposed to the body element between closed and open configurations by manual displacement of the actuation part of the delivery unit to provide for an air flow through the nosepiece simultaneously with delivery of substance.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: June 15, 2021
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Michael Leclerc, Ramy A Mahmoud, Shane Siwinski, Joseph Gordon, Justin Fisk
  • Publication number: 20190290863
    Abstract: A nasal delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: a nosepiece (117) for fitting to a nasal cavity of a subject; a mouthpiece (119) into which the subject in use exhales; a delivery unit, which comprises an actuation part which is manually displaceable to actuate the delivery unit to deliver substance from the nosepiece; and a valve assembly (127) which is fluidly connected to the nosepiece and the mouthpiece, wherein the valve assembly comprises a body element (128) and a valve element (131) which is movably disposed to the body element between closed and open configurations by manual displacement of the actuation part of the delivery unit to provide for an air flow through the nosepiece simultaneously with delivery of substance.
    Type: Application
    Filed: October 12, 2018
    Publication date: September 26, 2019
    Inventors: Per Gisle Djupesland, Michael Leclerc, Ramy A. Mahmoud, Shane Siwinski, Joseph Gordon, Justin Fisk
  • Patent number: 10300229
    Abstract: A nasal delivery device for and method of delivering substance to a nasal airway of a subject, the delivery device comprising: a nosepiece (117) for fitting to a nasal cavity of a subject; a mouthpiece (119) into which the subject in use exhales; a delivery unit, which comprises an actuation part which is manually displaceable to actuate the delivery unit to deliver substance from the nosepiece; and a valve assembly (127) which is fluidly connected to the nosepiece and the mouthpiece, wherein the valve assembly comprises a body element (128) and a valve element (131) which is movably disposed to the body element between closed and open configurations by manual displacement of the actuation part of the delivery unit to provide for an air flow through the nosepiece simultaneously with delivery of substance.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: May 28, 2019
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Michael Leclerc, Ramy A. Mahmoud, Shane Siwinski, Joseph Gordon, Justin Fisk
  • Publication number: 20190083722
    Abstract: A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject; a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece.
    Type: Application
    Filed: August 14, 2018
    Publication date: March 21, 2019
    Inventors: Per Gisle DJUPESLAND, Joseph Gordon, Michael Leclerc, Ramy A. Mahmoud, Shane Siwinski
  • Patent number: 10179216
    Abstract: A nasal delivery device comprising: a housing (15); a nosepiece (17) for fitting to a nasal cavity of a subject; a mouthpiece (19) through which the subject in use exhales; and a substance supply unit (21) including an actuation member (23) which extends from one end of the housing and is manually actuated to deliver substance to the nasal cavity of the subject; wherein the housing includes a grip section (27) which is disposed at the one end of the housing from which the actuation member extends, said grip section comprising a first, distal part (28) including at least one projecting grip element (29) by which the subject grips the housing in actuating the actuation member, and a second, proximal part (31) providing a recess (33) in which fingers of the subject are located, said recess promoting proper orientation of the delivery device in a hand of the subject.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: January 15, 2019
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Kate Dudgeon, Joseph Gordon, Mark Guarraia, Michael Leclerc, Ramy A Mahmoud
  • Patent number: 10076614
    Abstract: A nasal delivery device for delivering substance to a nasal cavity of a subject comprises: a housing (15); a nosepiece (17) for fitting to a nasal cavity of the subject; a mouthpiece (19) through which the subject in use exhales; and a flexible coupling (20) which couples the mouthpiece to the housing, wherein the flexible coupling provides for asymmetric translation of the mouthpiece relative to the nosepiece.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: September 18, 2018
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Joseph Gordon, Michael Leclerc, Ramy A Mahmoud, Shane Siwinski
  • Publication number: 20160367774
    Abstract: A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
    Type: Application
    Filed: July 1, 2016
    Publication date: December 22, 2016
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, John Messina
  • Publication number: 20160310683
    Abstract: A delivery device for and method of modulating a condition relating to sodal cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof, comprising: providing a nosepiece to a first nasal cavity of the subject; and providing a supply unit for administering less than 24 IU of oxytocin, non-peptide agonists thereof and/or antagonists thereof through the nosepiece to an upper region posterior of the nasal valve which is innervated by the trigeminal nerve.
    Type: Application
    Filed: November 19, 2015
    Publication date: October 27, 2016
    Inventors: Per Gisle Djupesland, Ramy A. Mahmoud, Ole A Andreassen, Lars T. Westlye, Daniel S. Quintana, Knut T. Smerud, Colin David Sheldrake
  • Publication number: 20150246194
    Abstract: A nasal delivery device comprising: a housing (15); a nosepiece (17) for fitting to a nasal cavity of a subject; a mouthpiece (19) through which the subject in use exhales; and a substance supply unit (21) including an actuation member (23) which extends from one end of the housing and is manually actuated to deliver substance to the nasal cavity of the subject; wherein the housing includes a grip section (27) which is disposed at the one end of the housing from which the actuation member extends, said grip section comprising a first, distal part (28) including at least one projecting grip element (29) by which the subject grips the housing in actuating the actuation member, and a second, proximal part (31) providing a recess (33) in which fingers of the subject are located, said recess promoting proper orientation of the delivery device in a hand of the subject.
    Type: Application
    Filed: February 25, 2013
    Publication date: September 3, 2015
    Inventors: Gisle Per Djupesland, Kate Dudgeon, Joseph Gordon, Mark Guarraia, Michael Leclerc, Ramy A. Mahmoud
  • Publication number: 20150144129
    Abstract: A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
    Type: Application
    Filed: June 25, 2014
    Publication date: May 28, 2015
    Inventors: Per Gisle DJUPESLAND, Ramy A. MAHMOUD, John MESSINA
  • Publication number: 20150053201
    Abstract: A method of delivering a substance, such as one or more of a triptan, a nasal steroid or carbon dioxide gas, to the nasal cavity of a subject, in particular for the treatment of headaches, for example, migraine, or rhinosinusitis, for example, chronic rhinosinusitis, optionally with polyps, the method comprising the steps of fitting a nosepiece to one nostril of the subject, delivering the substance through the nosepiece to the posterior region of the nasal cavity of the subject.
    Type: Application
    Filed: March 26, 2014
    Publication date: February 26, 2015
    Applicant: OPTINOSE AS
    Inventors: Per Gisle DJUPESLAND, Ramy A. MAHMOUD, John MESSINA
  • Patent number: D725769
    Type: Grant
    Filed: May 23, 2013
    Date of Patent: March 31, 2015
    Assignee: OptiNose AS
    Inventors: Per Gisle Djupesland, Kate Dudgeon, Justin Fisk, Joseph Gordon, Mark Guarraia, Michael Leclerc, Ramy A Mahmoud, Shane Siwinski